The next board meeting for Arcturus Therapeutics Holdings Inc is on 10 Nov 2025 for the purpose of Arcturus Therapeutics Holdings Inc Third Quarter Earnings Conference Call for 2025See details
Arcturus Therapeutics Holdings Inc has a share price target of US$ 45, revenue growth forecast of -42.0%, and profit growth estimate of 6.1% for FY25, based on top 11 analyst calls.